Despite the massive interest and recent developments in the field of nanomedicine, only a
limited number of formulations have found their way to the clinics. This shortcoming reveals …

In recent years, with the development of nanomaterials, the research of drug delivery
systems has become a new field of cancer therapy. Compared with conventional antitumor …

The uncontrolled release of drugs in conventional drug delivery systems has led to the
introduction of new nanotechnology-based drug delivery systems and the use of targeted …

Nanoengineered drug delivery systems (nDDS) have been successfully used as clinical
tools for not only modulation of pharmacological drug release profile but also specific …

Accurate and precise drug delivery is the key to successful therapy. Monoclonal antibodies,
which can transport therapeutic payload to cells expressing specific markers, have paved …

The epidermal growth factor receptor (EGFR) is vital for many different types of cancer.
Nimotuzumab (NmAb), an anti-EGFR monoclonal antibody (mAb), is used against some of …

Nanoparticles are designed to deliver therapeutics and diagnostics selectively to tumors.
Their size, shape, charge, material, coating, and cargo determine their individual …

Over the last decade, magnetic iron oxide nanoparticles have attracted considerable interest
in the field of nanomedicine due to their unique magnetic properties, biocompatibility, and …

Targeted delivery systems of nanobiomaterials are necessary to be developed for the
diagnosis and treatment of cancer. Nanobiomaterials can be engineered to recognize …

We developed a nano-antibody targeted chemotherapy (nATC) delivery strategy in which
tumor specific and clinically relevant antibodies (rituximab, anti-CD20) are non-covalently …